Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
Holders of 5% or more of BVS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bioventus Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 9.03%6.05M shares | +1.07 ppfrom 7.96% | Nov 14, 20243 filings | Feb 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Bioventus Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20265:02 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.03%6.05M shares | +1.07 ppfrom 7.96% | Dec 31, 2025 | SEC |
| Aug 14, 20254:31 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 7.96%5.28M shares | +1.27 ppfrom 6.69% | Jun 30, 2025 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 6.69%4.35M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bioventus Inc. shares.
No Form 144 notices for Bioventus Inc. are on file.